Key facts
- This page summarizes Michael Ellenbogen's Form 4 filing for Evolv Technologies Holdings, Inc. (EVLV).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Mar 2024, 17:21.
Michael Ellenbogen - 04 Mar 2024 Form 4 Insider Report for Evolv Technologies Holdings, Inc. (EVLV)
- Reporting relationship
- Founder & Chief Innovation Ofc, Director
- Issuer ticker
- EVLV
- Reported as of
- 04 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Mar 2024, 17:21:34 UTC
- Prior SEC filing
- 05 Mar 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Pyenson, Attorney-in-fact for Michael Ellenbogen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Ellenbogen filed Form 4 for Evolv Technologies Holdings, Inc. (EVLV) on 06 Mar 2024.
Change
- Previous filing in this sequence was filed on 05 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EVLV
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +172,176
- Change %
- Price
- $0.000000
- Shares after
- 172,176
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 172,176
- Exercise price
- Footnotes
- F1, F2
EVLV
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +225,631
- Change %
- Price
- $0.000000
- Shares after
- 225,631
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 225,631
- Exercise price
- $3.63
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.
Footnote F2
The RSUs vest in three equal annual installments commencing on March 1, 2025.
Footnote F3
The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2024 and in 15 equal quarterly installments thereafter.